MELISSA M BELLAMY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner STATESVILLE, NC NPI 1568938017
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner NC Acerta Pharma LLC All categories
General Payments — all program years on this page
$4,828.55
- Category: General Payments
- Program years: PY2021–2024
- Record count: 249
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $421.78 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $421.78 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $137.22 | 2 |
| Abbott Laboratories | $124.78 | 1 |
| SPR Therapeutics, Inc | $77.00 | 1 |
| Otsuka America Pharmaceutical, Inc. | $50.29 | 2 |
| Janssen Biotech, Inc. | $18.22 | 1 |
| Novo Nordisk AS | $14.27 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078329076 | Janssen Biotech, Inc. | $18.22 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100372028 | Novo Nordisk Inc | $14.27 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104347328 | AstraZeneca Pharmaceuticals LP | $124.05 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104955499 | SPR Therapeutics, Inc | $77.00 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105876997 | AstraZeneca Pharmaceuticals LP | $13.17 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119025078 | Otsuka America Pharmaceutical, Inc. | $20.71 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119025080 | Otsuka America Pharmaceutical, Inc. | $29.58 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125131500 | Abbott Laboratories | $124.78 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.